The Ile585Val TRPV1 variant is involved in risk of painful knee osteoarthritis
- PMID: 21616913
- PMCID: PMC3147243
- DOI: 10.1136/ard.2010.148122
The Ile585Val TRPV1 variant is involved in risk of painful knee osteoarthritis
Abstract
Objective: To assess if a coding variant in the gene encoding transient receptor potential cation channel, subfamily V, member 1 (TRPV1) is associated with genetic risk of painful knee osteoarthritis (OA).
Methods: The Ile585Val TRPV1 variant encoded by rs8065080 was genotyped in 3270 cases of symptomatic knee OA, 1098 cases of asymptomatic knee OA and 3852 controls from seven cohorts from the UK, the USA and Australia. The genetic association between the low-pain genotype Ile-Ile and risk of symptomatic and asymptomatic knee OA was assessed.
Results: The TRPV1 585 Ile-Ile genotype, reported to be associated with lower thermal pain sensitivity, was associated with a lower risk of symptomatic knee OA in a comparison of symptomatic cases with healthy controls, with an odds ratio (OR) of 0.75 (95% CI 0.64 to 0.88; p=0.00039 by meta-analysis) after adjustment for age, sex and body mass index. No difference was seen between asymptomatic OA cases and controls (OR=1.02, 95% CI 0.82 to 1.27 p=0.86) but the Ile-Ile genotype was associated with lower risk of symptomatic versus asymptomatic knee OA adjusting for covariates and radiographic severity (OR=0.73, 95% CI 0.57 to 0.94 p=0.0136). TRPV1 expression in articular cartilage was increased by inflammatory cytokines (tumour necrosis factor α and interleukin 1). However, there were no differences in TRPV1 expression in healthy and arthritic synovial tissue.
Conclusions: A genotype involved in lower peripheral pain sensitivity is significantly associated with a decreased risk of painful knee OA. This indicates a role for the pro-nociceptive gene TRPV1 in genetic susceptibility to symptomatic knee OA, which may also be influenced by a role for this molecule in cartilage function.
Conflict of interest statement
Figures


Similar articles
-
Role of the Nav1.7 R1150W amino acid change in susceptibility to symptomatic knee osteoarthritis and multiple regional pain.Arthritis Care Res (Hoboken). 2011 Mar;63(3):440-4. doi: 10.1002/acr.20375. Epub 2010 Oct 28. Arthritis Care Res (Hoboken). 2011. PMID: 21031562
-
Evaluation of NFKB1A variants in patients with knee osteoarthritis.Int J Immunogenet. 2013 Aug;40(4):272-9. doi: 10.1111/iji.12020. Epub 2012 Nov 23. Int J Immunogenet. 2013. PMID: 23176038
-
Expression of mitochondrial TSPO and FAM173B is associated with inflammation and symptoms in patients with painful knee osteoarthritis.Rheumatology (Oxford). 2021 Apr 6;60(4):1724-1733. doi: 10.1093/rheumatology/keaa565. Rheumatology (Oxford). 2021. PMID: 33067627 Free PMC article.
-
A meta-analysis of interleukin-6 promoter polymorphisms on risk of hip and knee osteoarthritis.Osteoarthritis Cartilage. 2010 May;18(5):699-704. doi: 10.1016/j.joca.2009.12.012. Epub 2010 Feb 6. Osteoarthritis Cartilage. 2010. PMID: 20175976
-
Large-scale meta-analysis of interleukin-1 beta and interleukin-1 receptor antagonist polymorphisms on risk of radiographic hip and knee osteoarthritis and severity of knee osteoarthritis.Osteoarthritis Cartilage. 2011 Mar;19(3):265-71. doi: 10.1016/j.joca.2010.12.003. Epub 2010 Dec 10. Osteoarthritis Cartilage. 2011. PMID: 21146623 Review.
Cited by
-
Emerging Targets for the Management of Osteoarthritis Pain.Curr Osteoporos Rep. 2016 Dec;14(6):260-268. doi: 10.1007/s11914-016-0326-z. Curr Osteoporos Rep. 2016. PMID: 27730452 Free PMC article. Review.
-
Hyaluronan modulates TRPV1 channel opening, reducing peripheral nociceptor activity and pain.Nat Commun. 2015 Aug 27;6:8095. doi: 10.1038/ncomms9095. Nat Commun. 2015. PMID: 26311398 Free PMC article.
-
Association between GDF5 rs143383 polymorphism and knee osteoarthritis: an updated meta-analysis based on 23,995 subjects.BMC Musculoskelet Disord. 2014 Dec 2;15:404. doi: 10.1186/1471-2474-15-404. BMC Musculoskelet Disord. 2014. PMID: 25467786 Free PMC article.
-
Anti-Inflammatory and Analgesic Effects of TRPV1 Polypeptide Modulator APHC3 in Models of Osteo- and Rheumatoid Arthritis.Mar Drugs. 2021 Jan 17;19(1):39. doi: 10.3390/md19010039. Mar Drugs. 2021. PMID: 33477357 Free PMC article.
-
Update on the pharmacogenomics of pain management.Pharmgenomics Pers Med. 2019 Jul 3;12:125-143. doi: 10.2147/PGPM.S179152. eCollection 2019. Pharmgenomics Pers Med. 2019. PMID: 31308726 Free PMC article. Review.
References
-
- Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367:1747–57 - PubMed
-
- Pincus T, Block JA. Pain and radiographic damage in osteoarthritis. BMJ 2009;339:b2802. - PubMed
-
- Felson DT, Naimark A, Anderson J, et al. The prevalence of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum 1987;30:914–18 - PubMed
-
- Lethbridge-Cejku M, Scott WW, Jr, Reichle R, et al. Association of radiographic features of osteoarthritis of the knee with knee pain: data from the Baltimore Longitudinal Study of Aging. Arthritis Care Res 1995;8:182–8 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources